{"id":543,"date":"2020-09-17T19:51:03","date_gmt":"2020-09-17T19:51:03","guid":{"rendered":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/?post_type=chapter&p=543"},"modified":"2020-12-07T16:21:08","modified_gmt":"2020-12-07T16:21:08","slug":"ch-13-4","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/chapter\/ch-13-4\/","title":{"rendered":"Ch. 14.4: References and Image Credits"},"content":{"raw":"

AlShareef, S., & Marwaha, R. (2019). Anabolic steroid use disorder. StatPearls [Internet], retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538174\/<\/a><\/p>\r\n

Baydala, L., & Canadian Paediatric Society, First Nations, Inuit and M\u00e9tis Health Committee. (2010). Inhalant abuse. Paediatrics & Child Health, 15<\/em>(7), 443-448.<\/p>\r\n

Centers for Disease Control and Prevention (CDC). (2013). Addressing prescription drug abuse in the United States: Current activities and future opportunities. Developed by the Behavioral Health Coordinating Committee, Prescription Drug Abuse Subcommittee, U.S. Department of Health and Human Services. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/hhs_prescription_drug_abuse_report_09.2013.pdf<\/a><\/p>\r\n

Center for Substance Abuse Treatment (CSAT). (2006). Detoxification and substance abuse treatment.<\/em> Treatment Improvement Protocol (TIP) Series, No. 45. HHS Publication No. (SMA) 15-4131. Rockville, MD: CSAT. Retrieved from https:\/\/store.samhsa.gov\/system\/files\/sma15-4131.pdf<\/a><\/p>\r\n

Chan, B.., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., & Kansagara, D. (2019). Pharmacotherapy for cocaine use disorder-A systematic review and meta-analysis. Journal of General Internal Medicine, 34<\/em>(12), 2858-2873.<\/p>\r\n

Department of Justice (DOJ). (2004). A guide for understanding steroids and related substances. U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division. Retrieved from https:\/\/www.deadiversion.usdoj.gov\/pubs\/brochures\/steroids\/professionals\/<\/a><\/p>\r\n

Dodds, T.J. (2017). Prescribed benzodiazepines and suicide risk: A review of the literature. The Primary Care Companion for CNS Disorders, 19<\/em>(2), e1-e6. Retrieved from http:\/\/www.psychiatrist.com\/PCC\/article\/Pages\/2017\/v19n02\/16r02037.aspx<\/a> \u00a0doi: 10.4088\/PCC.16r02037<\/p>\r\n

Humphreys, K., Malenka, R.C., Knutson, B., & MacCoun, R.J. (2017). Policy forum: Neuroscience and addiction\u2014Brains, environments, and policy responses to addiction. Science, 356<\/em>, 1237-1239.<\/p>\r\n

Lopez, G. (2016). It\u2019s not just painkillers and heroin. Americans have a growing alcohol problem too. Vox <\/em>(December 9). Retrieved from https:\/\/www.vox.com\/policy-and-politics\/2016\/12\/9\/13898956\/alcohol-deaths-2015<\/a><\/p>\r\n

Mattick, R.P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.<\/em> The Cochrane database of systematic reviews (3). Retrieved from https:\/\/researchonline.lshtm.ac.uk\/id\/eprint\/5044\/1\/5044.pdf<\/a><\/p>\r\n

National Center for Complementary and Integrative Health (NCCIH). (2018). St. John\u2019s Wort and depression: In depth. Retrieved from https:\/\/nccih.nih.gov\/health\/stjohnswort\/sjw-and-depression.htm<\/a><\/p>\r\n

National Institute on Drug Abuse (NIDA). (2017a). Inhalants. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/inhalants<\/a><\/p>\r\n

National Institute on Drug Abuse (NIDA). (2017b). Over-the-counter medicines. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/over-counter-medicines<\/a><\/p>\r\n

National Institute on Drug Abuse (NIDA). (2018a). Anabolic steroids. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/anabolic-steroids<\/a><\/p>\r\n

National Institute on Drug Abuse (NIDA). (2018b). Misuse of prescription drugs. Retrieved from https:\/\/www.drugabuse.gov\/publications\/misuse-prescription-drugs\/overview<\/a><\/p>\r\n

National Institute on Drug Abuse (NIDA). (2020). Opioid overdose reversal with naloxone (Narcan, Evzio). Retrieved from https:\/\/www.drugabuse.gov\/related-topics\/opioid-overdose-reversal-naloxone-narcan-evzio<\/a><\/p>\r\n

National Institute on Drug Abuse (NIDA). (n.d.). Buprenorphine. Retrieved from https:\/\/archives.drugabuse.gov\/buprenorphine<\/a><\/p>\r\n

Portelli, J., Munjal, V., & Leggio, L. (2020). Current and emerging pharmacotherapies for addiction treatment. In A.L. Begun & M. Murray, (Eds.), Routledge handbook of social work and addictive behaviors, <\/em>(p. 321-342). NY: Routledge.<\/p>\r\n

Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Natrexone. Retrieved from https:\/\/www.samhsa.gov\/medication-assisted-treatment\/treatment\/naltrexone<\/a><\/p>\r\n

Suh, J.J., Pettinati, H.M., Kampman, K.M., & O\u2019Brien, C.P. (2006). The status of disulfiram: A half of a century later., Journal of Clinical Psychopharmacology, 26<\/em>(3), 290-302.<\/p>\r\n

Witkiewitz, K., Saville, K., & Hamreus, K. (2012). Acamprosate for treatment of alcohol dependence: Mechanisms, efficacy, and clinical utility. Therapeutics and Clinical Risk Management, 8,<\/em> 45-53.<\/p>\r\n

World Health Organization (WHO). (1993). Drug use and sport: Current issues and implications for public health. Programme on substance abuse. Retrieved from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/60747\/WHO_PSA_93.3.pdf?sequence=1&isAllowed=y<\/a><\/p>\r\n

Zweben , A., & West, B. (2020). Intervening around addictive behaviors. In A.L. Begun & M. Murray, (Eds.), Routledge handbook of social work and addictive behaviors, <\/em>(p. 298-320). NY: Routledge.<\/p>","rendered":"

AlShareef, S., & Marwaha, R. (2019). Anabolic steroid use disorder. StatPearls [Internet], retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538174\/<\/a><\/p>\n

Baydala, L., & Canadian Paediatric Society, First Nations, Inuit and M\u00e9tis Health Committee. (2010). Inhalant abuse. Paediatrics & Child Health, 15<\/em>(7), 443-448.<\/p>\n

Centers for Disease Control and Prevention (CDC). (2013). Addressing prescription drug abuse in the United States: Current activities and future opportunities. Developed by the Behavioral Health Coordinating Committee, Prescription Drug Abuse Subcommittee, U.S. Department of Health and Human Services. Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/hhs_prescription_drug_abuse_report_09.2013.pdf<\/a><\/p>\n

Center for Substance Abuse Treatment (CSAT). (2006). Detoxification and substance abuse treatment.<\/em> Treatment Improvement Protocol (TIP) Series, No. 45. HHS Publication No. (SMA) 15-4131. Rockville, MD: CSAT. Retrieved from https:\/\/store.samhsa.gov\/system\/files\/sma15-4131.pdf<\/a><\/p>\n

Chan, B.., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., & Kansagara, D. (2019). Pharmacotherapy for cocaine use disorder-A systematic review and meta-analysis. Journal of General Internal Medicine, 34<\/em>(12), 2858-2873.<\/p>\n

Department of Justice (DOJ). (2004). A guide for understanding steroids and related substances. U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division. Retrieved from https:\/\/www.deadiversion.usdoj.gov\/pubs\/brochures\/steroids\/professionals\/<\/a><\/p>\n

Dodds, T.J. (2017). Prescribed benzodiazepines and suicide risk: A review of the literature. The Primary Care Companion for CNS Disorders, 19<\/em>(2), e1-e6. Retrieved from http:\/\/www.psychiatrist.com\/PCC\/article\/Pages\/2017\/v19n02\/16r02037.aspx<\/a> \u00a0doi: 10.4088\/PCC.16r02037<\/p>\n

Humphreys, K., Malenka, R.C., Knutson, B., & MacCoun, R.J. (2017). Policy forum: Neuroscience and addiction\u2014Brains, environments, and policy responses to addiction. Science, 356<\/em>, 1237-1239.<\/p>\n

Lopez, G. (2016). It\u2019s not just painkillers and heroin. Americans have a growing alcohol problem too. Vox <\/em>(December 9). Retrieved from https:\/\/www.vox.com\/policy-and-politics\/2016\/12\/9\/13898956\/alcohol-deaths-2015<\/a><\/p>\n

Mattick, R.P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.<\/em> The Cochrane database of systematic reviews (3). Retrieved from https:\/\/researchonline.lshtm.ac.uk\/id\/eprint\/5044\/1\/5044.pdf<\/a><\/p>\n

National Center for Complementary and Integrative Health (NCCIH). (2018). St. John\u2019s Wort and depression: In depth. Retrieved from https:\/\/nccih.nih.gov\/health\/stjohnswort\/sjw-and-depression.htm<\/a><\/p>\n

National Institute on Drug Abuse (NIDA). (2017a). Inhalants. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/inhalants<\/a><\/p>\n

National Institute on Drug Abuse (NIDA). (2017b). Over-the-counter medicines. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/over-counter-medicines<\/a><\/p>\n

National Institute on Drug Abuse (NIDA). (2018a). Anabolic steroids. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/anabolic-steroids<\/a><\/p>\n

National Institute on Drug Abuse (NIDA). (2018b). Misuse of prescription drugs. Retrieved from https:\/\/www.drugabuse.gov\/publications\/misuse-prescription-drugs\/overview<\/a><\/p>\n

National Institute on Drug Abuse (NIDA). (2020). Opioid overdose reversal with naloxone (Narcan, Evzio). Retrieved from https:\/\/www.drugabuse.gov\/related-topics\/opioid-overdose-reversal-naloxone-narcan-evzio<\/a><\/p>\n

National Institute on Drug Abuse (NIDA). (n.d.). Buprenorphine. Retrieved from https:\/\/archives.drugabuse.gov\/buprenorphine<\/a><\/p>\n

Portelli, J., Munjal, V., & Leggio, L. (2020). Current and emerging pharmacotherapies for addiction treatment. In A.L. Begun & M. Murray, (Eds.), Routledge handbook of social work and addictive behaviors, <\/em>(p. 321-342). NY: Routledge.<\/p>\n

Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Natrexone. Retrieved from https:\/\/www.samhsa.gov\/medication-assisted-treatment\/treatment\/naltrexone<\/a><\/p>\n

Suh, J.J., Pettinati, H.M., Kampman, K.M., & O\u2019Brien, C.P. (2006). The status of disulfiram: A half of a century later., Journal of Clinical Psychopharmacology, 26<\/em>(3), 290-302.<\/p>\n

Witkiewitz, K., Saville, K., & Hamreus, K. (2012). Acamprosate for treatment of alcohol dependence: Mechanisms, efficacy, and clinical utility. Therapeutics and Clinical Risk Management, 8,<\/em> 45-53.<\/p>\n

World Health Organization (WHO). (1993). Drug use and sport: Current issues and implications for public health. Programme on substance abuse. Retrieved from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/60747\/WHO_PSA_93.3.pdf?sequence=1&isAllowed=y<\/a><\/p>\n

Zweben , A., & West, B. (2020). Intervening around addictive behaviors. In A.L. Begun & M. Murray, (Eds.), Routledge handbook of social work and addictive behaviors, <\/em>(p. 298-320). NY: Routledge.<\/p>\n","protected":false},"author":236,"menu_order":4,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[],"contributor":[],"license":[],"class_list":["post-543","chapter","type-chapter","status-publish","hentry"],"part":534,"_links":{"self":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/users\/236"}],"version-history":[{"count":4,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/543\/revisions"}],"predecessor-version":[{"id":993,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/543\/revisions\/993"}],"part":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/parts\/534"}],"metadata":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapters\/543\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/media?parent=543"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/pressbooks\/v2\/chapter-type?post=543"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/contributor?post=543"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ulib.csuohio.edu\/substancemisusepart1\/wp-json\/wp\/v2\/license?post=543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}